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We previously reported that residues 299 –318 in Gai1
participate in the selective interaction between Gai1
and the 5-hydroxytryptamine1B (5-HT1B) receptor (Bae,
H., Anderson, K., Flood, L. A., Skiba, N. P., Hamm, H. E.,
and Graber, S. G. (1997) J. Biol. Chem. 272, 32071–32077).
The present study more precisely defines which residues within this domain are critical for 5-HT1B receptormediated G protein activation. A series of Gai1/Gat chimeras and point mutations were reconstituted with Gbg
and Sf9 cell membranes containing the 5-HT1B receptor.
Functional coupling to 5-HT1B receptors was assessed
by 1) [35S]GTPgS binding and 2) agonist affinity shift
assays. Replacement of the a4 helix of Gai1 (residues
299 –308) with the corresponding sequence from Gat produced a chimera (Chi22) that only weakly coupled to the
5-HT1B receptor. In contrast, substitution of residues
within the a4-b6 loop region of Gai1 (residues 309 –318)
with the corresponding sequence in Gat either permitted full 5-HT1B receptor coupling to the chimera (Chi24)
or only minimally reduced coupling to the chimeric protein
(Chi25). Two mutations within the a4 helix of Gai1 (Q304K
and E308L) reduced agonist-stimulated [35S]GTPgS binding, and the effects of these mutations were additive. The
opposite substitutions within Chi22 (K300Q and L304E) restored 5-HT1B receptor coupling, and again the effects of
the two mutations were additive. Mutations of other residues within the a4 helix of Gai1 had minimal to no effect on
5-HT1B coupling behavior. These data provide evidence
that a4 helix residues in Gai participate in directing specific receptor interactions and suggest that Gln304 and
Glu308 of Gai1 act in concert to mediate the ability of the
5-HT1B receptor to couple specifically to inhibitory G
proteins.

The interaction of heptahelical receptors with their cognate
heterotrimeric guanine nucleotide-binding proteins (G proteins) represents an initial step in the transmission of extracellular signals across the plasma membrane (2– 4). The recep* This work was supported by National Institutes of Health Grant
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tor-G protein interaction modulates specific second messenger
systems that result in a unique physiologic response to the
extracellular signal. The particular downstream effect of G
protein activation is not the result of an explicit interaction
between each heptahelical receptor and a unique heterotrimeric G protein. On the contrary, G protein-coupled receptors
have repeatedly been demonstrated to couple to several related
members within the same family of G protein a subunits, albeit
with differing levels of efficiency (5–11). Clawges et al. (12)
demonstrated that the serotonin (5-HT)1 1B receptor couples to
heterotrimers containing either Gai1, Gai2, Gai3, or Gao. Nevertheless, this receptor does not couple to heterotrimers containing another member of this same family, the Gat subunit
(12). Therefore, the 5-HT1B receptor represents one receptor
system that can be exploited to investigate the precise molecular determinants governing selective receptor-G protein
interactions.
Numerous biochemical studies have suggested that several
subregions of Ga (13–21) in addition to regions on Gb (20, 21)
and Gg (22–25) may act in concert to determine selective receptor-G protein interactions. The carboxyl-terminal domain of
Ga subunits, in particular, has been demonstrated to play a
key role in eliciting several specific receptor-G protein interactions. However, the carboxyl-terminal regions of Gai1, Gai2,
Gai3, and Gat are highly homologous, and therefore, the carboxyl-terminal domain is not likely to be the primary determinant of 5-HT1B receptor-G protein selectivity between Gai/o and
Gat. The selectivity profile of the 5-HT1B receptor has facilitated the use of Gai/Gat chimeras to map the residues that play
a role in determining the specific interaction of the 5-HT1B
receptor to inhibitory G proteins.
By using this approach, we previously demonstrated that
substitution of the a4 helix and a4 –b6 loop (amino acids 299 –
318) regions of Gai with the respective sequence from Gat
markedly reduced the ability of this chimera to couple to the
5-HT1B receptor (1). These studies determined that the region
corresponding to amino acids 299 –318 in Gai1 plays a key role
in determining the selective interaction between Gai1 and the
5-HT1B receptor (1). The intent of the present study was to
define more precisely which amino acids within this domain
are critical for selective 5-HT1B receptor coupling to inhibitory
G proteins.
In addition to providing a useful model for receptor-G protein
selectivity, the 5-HT1B receptor plays an important modulatory
role in the central nervous system. 5-HT1B receptors are the
primary terminal autoreceptors within the brain serotonin system (26). Activation of these receptors inhibits the release of
1
The abbreviations used are: 5-HT, 5-hydroxytryptamine; GTPgS,
guanosine 59-3-O-(thio)triphosphate; AMP-PNP, adenosine 59-(b,g imino)triphosphate; ANOVA, analysis of variance; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.
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5-HT into the synaptic cleft (27, 28). In addition, drugs that
selectively interact with 5-HT1B receptors have proven to be
clinically useful for the treatment of migraine headache (29).
Thus, deducing the molecular events that are essential to
5-HT1B receptor-catalyzed G protein activation may aid our
understanding of both normal and pathologic processes in
brain serotonin systems.
By utilizing a series of Gai/Gat chimeras coupled with sitedirected mutagenesis, the present study reveals that a4 helical
residues Gln304 and Glu308 of Gai1 are critical determinants of
5-HT1B receptor coupling to inhibitory G proteins. This conclusion is supported by the observed marked reduction in receptorcatalyzed GDP/GTP exchange on Gai1 Q304K, E308L, and
Q304K-E308L mutants. Moreover, whereas Gln304 and Glu308
are absolutely conserved among all Gai/o isoforms, they are
divergent between Gai/o and Gat subunits. The crystal structure of Gai reveals that Gln304 and Glu308 are surface-exposed
(30, 31), and mutation of these residues (Q304K and E308L)
may alter the surface potential of the a subunit. Hence, these
residues may interact directly with the 5-HT1B receptor to
mediate receptor coupling. Mutation of these residues may also
indirectly influence the secondary structure of neighboring domains resulting in an inability of the 5-HT1B receptor to couple
to the mutant inhibitory a subunits.
EXPERIMENTAL PROCEDURES

Materials—Nucleotides and enzymes were purchased either from
Boehringer Mannheim or from Amersham Pharmacia Biotech. Serotonin was obtained from Sigma. [35S]GTPgS (1250 Ci/mmol) and [3H]5HT (22–30 Ci/mmol) were purchased from NEN Life Science Products.
Construction of Ga Mutant Genes—The present study used the Escherichia coli expression vectors pHis6Gai1 or pHis6Chi3 that contain a
nucleotide sequence encoding a hexa-histidine tag under the control of
a T7 promoter (32). BamHI and HindIII digestion of pHis6Chi3 released
a 450-base pair DNA fragment corresponding to amino acid residues
214 –354 of Chi3. This fragment was subcloned into pUC19 (pUC19Chi3). To construct Chi22, Chi24, and Chi25, duplex oligonucleotides
containing the desired mutations were ligated into the NaeI- and BglIIdigested pUC19-Chi3. Sequences were confirmed, and the correct
pUC19-based chimeras were cloned into the pHis6Gai1 as a BamHI and
HindIII fragment. Generation of the BamHI site in pHis6Gai1 did not
mutate any residues. Site-directed mutagenesis of either Chi22 or Gai1
was carried out using the QuikChangeTM Site-directed Mutagenesis Kit
(Stratagene, La Jolla, CA) according to the manufacturer’s instructions.
Either pHis6Gai1 or pHis6Chi22 served as the template for polymerase
chain reaction-based mutagenesis.
Expression and Purification of Gai1 and Ga Mutants in E. coli—
Hexa-histidine-tagged Gai1 or chimeric Ga subunits were expressed in
E. coli BL21(DE3) cells and purified as described (32) with minor
modification. Briefly, cell pellets were resuspended in buffer A (50 mM
Tris-HCl, pH 8.0, 50 mM NaCl, 5 mM MgCl2) supplemented with 50 mM
GDP, 0.1 mM phenylmethylsulfonyl fluoride, and 5 mM b-mercaptoethanol, sonicated, and then centrifuged at 100,000 3 g for 60 min. The
supernatant was loaded onto a Ni21-nitrilotriacetic acid-agarose resin
column (His-Bond, Novagen). Eluted samples were dialyzed overnight
against buffer A in the presence of 20% glycerol, 0.1 mM phenylmethylsulfonyl fluoride, and 2 mM b-mercaptoethanol and then further purified by high performance liquid chromatography (Waters Protein-Pak
QHR-15, Waters Chromatography). Protein concentrations were determined using the Coomassie Blue method (33) with bovine serum albumin (Pierce) as the standard.
Expression and Purification of G Protein Subunits—For affinity shift
assays, the expression and purification of the G protein a subunits in
Sf9 cells was performed as described (34, 35) except that the final
chromatography step was performed on 15-micron Waters Protein-Pak
QHR (Waters Chromatography). Recombinant b1g2 subunits were purified from Sf9 cells using a His6-g2 as described by Kozasa and Gilman
(36). The native retinal bg subunits used for the GTPgS binding experiment were purified as described (37).
Preparation of Sf9 Membranes Containing 5-HT1B-expressed Receptors—Sf9 cells were infected with recombinant baculovirus containing
cDNA for the 5-HT1B receptor, cultured, and harvested as described
(34). Membranes were prepared according to a previously published
protocol (1). Briefly, harvested cells were thawed and resuspended in

ice-cold homogenization buffer (10 mM Tris-HCl, pH 8.0, 25 mM NaCl,
10 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 20 mg/ml benzamidine and 2 mg/ml each of aprotinin,
leupeptin, and pepstatin A) and burst by N2 cavitation. Cavitated cells
were centrifuged at low speed; the supernatant was removed and then
centrifuged at 28,000 3 g for 30 min at 4 °C. The resulting pellets were
resuspended in 5 mM NaHEPES, pH 7.5, containing 1 mM EDTA and
supplemented with the aforementioned protease inhibitors. The membranes were washed twice and resuspended in the same buffer (1–3 mg
of protein/ml).
Reconstitution of Receptors with Exogenous G Proteins—Frozen Sf9
membranes were reconstituted as described (1). Briefly, membranes
were pelleted and resuspended in reconstitution buffer (5 mM NaHEPES, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 500 nM GDP,
0.04% CHAPS). G protein subunits were diluted in the same buffer,
and the mixture was incubated at 25 °C for 15 min and then held on ice.
The reconstitution mixture was diluted with binding assay buffer as
described (1).
[3H]5-Hydroxytryptamine Binding Assay—[3H]5-HT binding to
5-HT1B receptors reconstituted with Ga and Gb1g2 was determined as
described previously (1). To estimate receptor number in individual
membrane preparations, the membranes were reconstituted with a
large excess (5 mM) of G protein heterotrimers containing Gai1 and the
5-HT1B receptors labeled with 1, 10, and 40 nM [3H]5-HT. It has been
shown that such reconstitution effectively converts all of the expressed
receptors to a coupled, high affinity for agonist state (12). Bmax values
were estimated by nonlinear regression analysis with GraphPad
PRISM of the specific binding data using a fixed value (0.62 nM) for the
high affinity KD (12). For affinity shift assays, high affinity binding to
5-HT1B receptors was determined using a single concentration of [3H]5HT near the KD value for the radioligand (0.8 –1.3 nM).
5-HT1B Receptor-stimulated GTPgS Binding Assay—A GTPgS binding assay was used to quantitate receptor-catalyzed GDP/GTP exchange on Ga subunits as described (1). Briefly, membranes were
incubated with 1 mM AMP-PNP at 37 °C for 1 h, and receptor coupling
was reconstituted with Ga and Gbg subunits on ice in 70 ml of reaction
buffer A (25 mM Hepes, pH 7.4, 5 mM MgCl2, 1 mM EDTA, 100 mM NaCl,
1 mM dithiothreitol) for 30 min and then diluted with 200 ml of reaction
buffer A containing 150 nM GDP and 60 nM GTPgS. The addition of 30
ml of [35S]GTPgS (;7 3 106 cpm) initiated the reaction which was
incubated at 25 °C. The following final concentrations were used for the
GTPgS assay: 1.28 nM 5-HT1B, 40 nM Ga, and 40 nM retinal bg. For
agonist activation, 1 mM of 5-HT was included. Aliquots (20 ml) were
withdrawn at various times, and the reaction was terminated by filtration. Radioactivity retained on the filters was quantitated with a liquid
scintillation counter. As the actual receptor densities and protein concentrations varied in different experiments, some degree of variation in
the absolute level of GTPgS binding was observed. As rhodopsin can
couple to either Gt or Gi heterotrimers with equal efficiency (32), GTPgS
binding data were normalized to the percent of maximal binding that
occurred after incubating samples for 30 min in the presence of an
excess amount (500 nM) of light-activated rhodopsin.
Fluorescence Assay—To ensure that recombinant Ga proteins are
properly folded, instrinsic fluorescence of the subunits was measured as
described (1, 32). Briefly, the AlF2
4 -dependent conformational changes
of activated Ga subunits were monitored by intrinsic tryptophan fluorescence changes with excitation at 280 nm and emission at 340 nm.
The relative increase in fluorescence of 200 nM Ga subunits was determined from absorbance readings before and after the addition of 10 mM
NaF and 20 mM AlCl3.
Statistics—Affinity shift activity data and the initial rates of GDP/
GTP exchange (Table I) were analyzed separately using a one-way
analysis of variance (ANOVA). Differences between groups were determined by a Newman Keuls’ post hoc test only after the ANOVA yielded
a significant main effect.
RESULTS

The ability of 5-HT1B receptors to couple selectively to heterotrimers containing members of the Gai/o family of G proteins
(12) facilitated the use of a series of Gai/Gat chimeras to determine which amino acids within Gai mediate this specific interaction. By using this approach, we previously demonstrated
that Gai1 amino acid residues 299 –318 (corresponding to the
a4 helix and a4-b6 loop regions of Gai1) play a major role in
determining the selective interaction with the 5-HT1B receptor
(1). Additional residues in the amino-terminal domain of Gai1
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FIG. 1. Secondary structure and AlF2
4 -dependent tryptophan
fluorescence change of Ga subunits. Numbers above the wild type
forms of Gai1 and Gat represent the corresponding residues in each
respective a subunit. Numbers above chimeric structures indicate the
junction points of Gat and Gai1 sequences and refer to amino acid
positions in Gat. *, diagram of secondary structural domains common to
Ga subunits. SI, SII, and SIII refer to the switch regions of Ga. a Percent increase in tryptophan fluorescence in the presence of 10 mM NaF
and 20 mM AlCl3 compared with basal (see “Experimental Procedures”
for detail). The increase in tryptophan fluorescence indicates that all
constructs were capable of undergoing conformational change in the
b
presence of AlF2
As full-length Gat is not easily expressed or purified,
4.
this Gai1/Gat chimera was generated previously, crystallized, and
shown to exhibit at-like coupling activity (32, 51).

were also determined to play a secondary role in 5-HT1B receptor coupling (1).
The a4 Helical Domain of Gai1 Mediates the Ability of the
5-HT1B Receptor to Couple to Inhibitory G Proteins—The present study initially used the same approach described above to
identify which subdomain within this stretch of amino acids
(Gai1 299 –318) is critical for functional 5-HT1B receptor coupling to inhibitory G proteins. As shown schematically in Fig. 1,
three chimeric Gai/Gat proteins were generated in which either
the a4 helix (Chi22) or portions of the a4 –b6 loop region (Chi24
and Chi25) of Gai1 were replaced with the corresponding sequence from Gat. Prior to the assessment of coupling activity,
the ability of each chimeric Ga subunit to bind GDP and undergo conformational change upon binding to GTP was tested
by determining if the proteins undergo an AlF2
4 -dependent
increase in tryptophan fluorescence (32). This assay is based on
the ability of AlF2
4 , which mimics the g-phosphate of GTP, to
induce the active conformation, which then results in an increase in intrinsic fluorescence of Trp211 in Gai1. Tryptophan
fluorescence of all mutants and Gai1 used in this study increased 40 – 45% upon the addition of AlF2
4 (Fig. 1), consistent
with our previous results (1, 32).
Functional coupling between the 5-HT1B receptor and the
chimeric proteins was assessed by examining both the ability of
the 5-HT receptor agonist, serotonin, to stimulate receptorcatalyzed GDP/[35S]GTPgS exchange on the a subunit, and the
ability of the chimeric protein to induce the high affinity agonist binding state of the receptor (affinity shift activity). The
underlying principle of the affinity shift assay is that activated
receptors can be converted to a high affinity agonist binding
state by the appropriate G protein heterotrimers (12). By using
a low concentration of agonist near the KD for the high affinity
state and well below the KD for the low affinity state, the
formation of a functional agonist-receptor-G protein complex is
readily detected as an enhanced level of ligand binding. This
assay can detect changes in coupling with either native or
recombinant receptor and G protein preparations (12, 38 – 40).
As shown in Fig. 2A, 5-HT stimulation of the 5-HT1B receptor
results in a time-dependent increase in [35S]GTPgS binding to
recombinant Gai1. Substitution of the a4 helix of Gai1 with the
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FIG. 2. Time-dependent 5-HT1B receptor-catalyzed GDP/GTP
exchange on Gai1 and Gai1/Gat chimeras. Membranes expressing
the 5-HT1B receptor were reconstituted with either 40 nM Gai1 (A),
Chi22 (B), Chi24 (C), or Chi25 (D) in the presence of 40 nM b1g1. Data
are expressed as the percentage of maximal GTPgS binding obtained in
the presence of excess (500 nM) light-activated rhodopsin. Squares
indicate GTPgS binding in the presence of 1 mM 5-HT (added at the
8.5-min time point), and triangles indicate the binding in the absence of
agonist. Data represent the mean 6 S.E. from three independent
experiments.

corresponding sequence from Gat (Chi22) dramatically reduces
(290%) the ability of the 5-HT1B receptor to couple to the
chimeric G protein, as indicated by a marked reduction in the
ability of 5-HT to stimulate [35S]GTPgS binding to the Chi22 a
subunit (Fig. 2B and Table I). In contrast, substitution of the
a4 –b6 loop Gai1 residues 308 –314 with the corresponding region from Gat (Chi24) failed to alter serotonin-stimulated receptor-catalyzed incorporation of [35S]GTPgS into the chimeric
a subunits (Fig. 2C and Table I). Interestingly, an overlapping
chimera, Chi25, with Gai residues 305–314 substituted with
the corresponding Gat residues shows a modest (28%) but
significant (p , 0.05) reduction in the initial rate of GDP/GTP
exchange (Table I).
The coupling ability of these same chimeras (Chi22, Chi24,
and Chi25) was also examined by agonist affinity shift activity.
Consistent with the [35S]GTPgS experiments, the affinity shift
activity of Chi22 was significantly reduced (253%) in comparison to recombinant Gai1 (Fig. 3 and Table I). Likewise, as
expected from the GTPgS data, the affinity shift activity of
Chi24 did not significantly differ from Gai1. In contrast, although the affinity shift activity of Chi25 was reduced by 22%,
this reduction did not reach statistical significance (Table I,
Fig. 3). Taken together, these results localized the major molecular elements underlying the selective interaction of the
5-HT1B receptor with Gai1 to the a4 helical domain.
Amino Acid Residues Gln304 and Glu308 of Gai Are Critical
Determinants of Coupling to 5-HT1B Receptors—In order to
map more precisely the specific amino acids that are critical for
5-HT1B receptor coupling to Gai1, systematic site-directed mutagenesis studies were conducted based on either Chi22 or Gai1
(Fig. 4). Within Chi22 there are 5 residues that are divergent
between Gai1 and Gat: Gai1-A300G, A301N, Q304K, C305V,
and E308L (Fig. 4). Previous studies demonstrated that mutation of Gai1 residue Ala300 to glycine did not impair coupling to
the 5-HT1B receptor (1). Therefore, the present studies focused
only on divergent residues between Gai1301 and Gai1308. The
aim of the substitutions within Chi22 was to determine
whether coupling to the 5-HT1B receptor could be restored by
replacing Gat residues individually or in combination with the
corresponding residues from Gai1. Mutants based on Chi22
(Chi22-N297A, Chi22-K300Q, Chi22-V301C, Chi22-L304E,

14966

a4 Helical Residues of Gai1 Mediate 5-HT1B Receptor Coupling

TABLE I
Affinity shift activity and initial rates of GDP/GTP exchange
Affinity shift data represent the means 6 S.E. from 3 to 18 independent experiments. Initial rate data represent the means 6 S.E. from 3
independent experiments. Affinity shift and initial rate data were analyzed separately using a one-way analysis of variance followed by a Newman
Keuls’ post hoc test.
Gai1 mutants

Affinity shifta

Initial rateb

Gai1
Gai1-A301N
Gai1-C305V
Gai1-Q304K
Gai1-Q304K-C305V
Gai1-E308L
Gai1-C305V-E308L
Gai1-Q304K-E308L

3.95 6 0.20
4.90 6 0.32
4.88 6 0.14
4.51 6 0.13
4.03 6 0.22
3.45 6 0.43
3.73 6 0.43
3.18 6 0.38

870 6 74.6
977 6 40.6c
846 6 49.8
463 6 32.7c
465 6 32.4c
261 6 18.8c
261 6 23.8c
140 6 13.9c,e

Chimeras and Chi22 mutants

Chi24
Chi25
Chi22
Chi22-N297A
Chi22-V301C
Chi22-K300Q
Chi22-L304E
Chi22-K300Q-L304E

Affinity shifta

Initial rateb

3.63 6 0.43
3.06 6 0.44
1.86 6 0.14c
1.97 6 0.16c
2.71 6 0.01
2.65 6 0.16
3.19 6 0.25d
4.51 6 0.29d,g

756 6 53.5
629 6 41.5c
88 6 7.3c
40 6 26.8c
67 6 6.5c
215 6 17.6c,d
382 6 33.3c,d
799 6 35.2d,f

a
Affinity shift activities refer to the -fold enhancement above buffer controls of high affinity [3H]5-HT binding to 5-HT1B receptors reconstituted
with G protein heterotrimers containing the indicated a subunits.
b
Initial rates of GDP/GTP exchange were calculated from the binding curves (Fig. 5A and Fig. 6A) and expressed as pmol of GTPgS bound per
mole of protein per s.
c
Significantly different than corresponding Gai1 value (p , 0.05).
d
Chi22 mutants which are significantly greater than corresponding Chi22 value (p , 0.05).
e
Significantly lower than Gai1-Q304K initial rate value (p , 0.05).
f
Significantly greater than Chi22-K300Q and Chi22-L304E (p , 0.05).
g
Chi22 mutant with an affinity shift value which is significantly different than Chi22-K300Q and Chi22-V301C (p , 0.05).

FIG. 3. Affinity shift activity of Gai1/Gat chimeras with 5-HT1B
receptors. Affinity shift activities refer to the -fold enhancement above
buffer controls of high affinity [3H]5-HT binding to 5-HT1B receptors
reconstituted with G protein heterotrimers containing the indicated a
subunits. Data represent the mean 6 S.E. from 5 to 9 independent
determinations using three separate membrane preparations where
5-HT1B receptors were expressed between 5.2 and 11.7 pmol/mg membrane protein. Exogenous G proteins were 1.3–3.3 mM during reconstitution and 45–112 nM during the binding assays which was a 35–50-fold
molar excess over receptors. The concentration of [3H]5-HT was 0.8 –1.3
nM in all experiments. Data were analyzed using a one-way ANOVA
followed by a Newman Keuls’ post hoc test as described under “Experimental Procedures.” *, significantly lower than Gai1 (p , 0.05).

and Chi22-K300Q-L304E) demonstrated varying degrees of receptor-catalyzed GDP/GTP exchange (Fig. 5A and Table I) and
affinity shift activity (Fig. 5B and Table I). Similar to Chi22,
Chi22-N297A exhibited only very weak coupling to the 5-HT1B
receptor as exemplified both by the low levels of agonist-stimulated GTPgS binding (Fig. 5A, Table I) and by the low affinity
shift activity of the mutant chimeras (Fig. 5B). Mutation of
valine 301 to cysteine in Chi22 clearly failed to elevate the
initial rate of GTPgS binding above Chi22 (Table I and Fig. 5A).
Likewise, the affinity shift activity of this mutant did not
significantly differ from Chi22. Mutants Chi22-K300Q and
Chi22-L304E exhibited significant (p , 0.05) 2– 4-fold increases in agonist-stimulated GDP/GTP exchange in comparison to the parent Chi22 (Table I). Consistent with these data,
enhanced 5-HT1B receptor coupling was also observed with
Chi22-L304E as measured by a significant 72% increase in the
affinity shift activity over Chi22 (Fig. 5B). Although Chi22K300Q caused a 42% increase in affinity shift activity over that
observed for Chi22, this increase did not reach statistical significance. The critical nature of residues Gln304 and Glu308 is
supported by the observation that the double mutant Chi22K300Q-L304E completely restored GDP/GTP exchange and affinity shift activity to wild type Gai1 levels (Fig. 5 and Table I).
To confirm and further support the contention that Gai res-

FIG. 4. Primary sequence alignment of the a4 –a4/b6 loop region of bovine Gai1 (residues 296 –318) and Gat (residues 292–
314). Numbers immediately above the primary sequence of Gai1 correspond to residues in Gai1. Numbers immediately below the primary
sequence of Gat correspond to residues in Gat. The box indicates the
region of Gai1 that was substituted with the corresponding sequence
from Gat to generate Chi22. Boldface letters indicate residues within
Gat which diverge from Gai1 residues. Single or double mutations of
Gai1 or Chi22 are listed below the sequence alignment.

idues Gln304 and Glu308 are particularly important determinants of 5-HT1B receptor coupling, single or double mutations
were constructed in Gai1 (A301N, Q304K, C305V, and E308L).
The aim of these experiments was to determine whether coupling to the 5-HT1B receptor could be reduced or eliminated by
replacing these specific Gai1 residues with the corresponding
residues from Gat. As illustrated in Fig. 6A and Table I, the
single amino acid substitution Gai1-E308L markedly (270%)
and significantly (p , 0.05) reduced agonist-mediated stimulation of GTPgS binding to the mutant a subunit. Likewise,
mutation Gai1-Q304K resulted in a moderate (.40%; p , 0.05)
reduction in agonist-mediated GTPgS binding in comparison to
recombinant Gai1. Consistent with these data, the double mutant Gai1-Q304K-E308L exhibited an even greater reduction in
agonist-mediated GTPgS binding than either single mutation
alone (Fig. 6A and Table I). Gai1-C305V did not significantly
alter coupling to the 5-HT1B receptor as evidenced by the lack
of effect on agonist-stimulated GDP/GTP exchange with this
mutant (Table I). Quite unexpectedly, Gai1-A301N resulted in
a small (112%) but statistically significant (p , 0.05) increase
in the initial rate of GDP/GTP exchange in comparison to Gai1
(Table I). In contrast to the marked reductions in [35S]GTPgS
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FIG. 5. Functional coupling of the 5-HT1B receptor to Chi22
mutants. Membranes expressing the 5-HT1B receptor were reconstituted with the indicated Chi22 mutants and bg subunits. A illustrates
5-HT1B receptor-catalyzed GDP/GTP exchange on Chi22 point mutants.
Data are expressed as the percentage of maximal GTPgS binding obtained in the presence of excess (500 nM) light-activated rhodopsin.
Curves depict the difference between the rates of GTPgS binding in the
presence and absence of 1 mM 5-HT. Data shown represent the mean 6
S.E. of three independent experiments. The initial rates of nucleotide
exchange calculated from these data are shown in Table I. B depicts the
affinity shift activity of Chi22 mutants with 5-HT1B receptors. Affinity
shift activities refer to the -fold enhancement above buffer controls of
high affinity [3H]5-HT binding to 5-HT1B receptors reconstituted with G
protein heterotrimers containing the indicated a subunits. Data represent the mean 6 S.E. from 3 to 9 independent determinations using
three separate membrane preparations where 5-HT1B receptors were
expressed between 5.2 and 11.7 pmol/mg membrane protein. Exogenous
G proteins were 1.3–3.3 mM during reconstitution and 45–112 nM during
the binding assays which was a 35–50-fold molar excess over receptors.
The concentration of [3H]5-HT was between 0.8 and 1.3 nM in all
experiments. Data were analyzed using a one-way ANOVA followed by
a Newman Keuls’ post hoc test as described under “Experimental Procedures.” *, significantly greater than Chi22 (p , 0.05); #, significantly
greater than Chi22-K300Q.

binding observed with Gai1 mutants E308L, Q304K, and
Q304K-E308L, no significant differences in affinity shift activities were observed between these mutants and Gai1 (Table I
and Fig. 6B). Affinity shift activity also did not significantly
vary between Gai1 and Gai1-A301N, C305V, or C305V/E308L
(Table I).
This lack of correspondence between affinity shift activity
and [35S]GTPgS binding data for the Gai1 mutants is likely to
result from differences in the sensitivity of these assays stemming from technical aspects involved in these measures. For
example, the initial exchange rates (Table I) are determined
from linear regression analysis of the [35S]GTPgS binding data
generated over the course of 10 min following the introduction
of agonist to the assay (see Figs. 5A and 6A) with saturation of
[35S]GTPgS binding occurring by 30 min (Fig. 2A). In contrast,
as is required for radioligand binding assays, the affinity of
[3H]5-HT for the 5-HT1B receptor is determined only after
equilibrium is reached (i.e. following a 1.5-h incubation with
the agonist) and in the absence of GTP. Therefore, if GDP
release is impaired in the Gai1 mutants (as would be suggested
by alterations in [35S]GTPgS binding) but not prevented, sufficient GDP could be released over the course of the experiment
(1.5 h) such that at equilibrium the amount of high affinity
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FIG. 6. Functional coupling of the 5-HT1B receptor to Gai1 mutants. Membranes expressing the 5-HT1B receptor were reconstituted
with the indicated Gai1 mutants and bg subunits. A illustrates 5-HT1B
receptor-catalyzed GDP/GTP exchange on Gai1 point mutants. Data are
expressed as the percentage of maximal GTPgS binding obtained in the
presence of excess (500 nM) light-activated rhodopsin. Curves depict the
difference between the rates of GTPgS binding in the presence and
absence of 1 mM 5-HT. Data shown represent the mean 6 S.E. of three
independent experiments. The initial rates of nucleotide exchange calculated from these data are shown in Table I. B depicts the affinity shift
activity of Gai1 mutants with 5-HT1B receptors. Affinity shift activities
refer to the -fold enhancement above buffer controls of high affinity
[3H]5-HT binding to 5-HT1B receptors reconstituted with G protein
heterotrimers containing the indicated a subunits. Data represent the
mean 6 S.E. from 3 to 6 independent determinations using 2 separate
membrane preparations where 5-HT1B receptors were expressed between 5.2 and 11.7 pmol/mg membrane protein. Exogenous G proteins
were 1.3–3.3 mM during reconstitution and 45–112 nM during the binding assays which was a 35–50-fold molar excess over receptors. The
concentration of [3H]5-HT was between 0.8 and 1.3 nM in all experiments. Data were analyzed using a one-way ANOVA followed by a
Newman Keuls’ post hoc test as described under “Experimental Procedures.” There were no significant differences between the affinity shift
activity of Gai1 and those of the mutant Ga subunits.

receptors present in the preparation is similar for both Gai1
and the Gai1 mutants. Alternatively, the divergence between
affinity shift activity and [35S]GTPgS binding for the Gai1
mutants may be indicative of a change in GTPgS binding in the
absence of a change in GDP release. This situation could only
arise if GTPgS binding (rather than GDP release) has become
the rate-limiting step as a result of the Gai1-Q304K and Gai1E308L mutations. If this were the case, we might expect to
observe this same phenomenon with the Chi22-K300Q, Chi22L304E, and Chi22-K300Q-L304E mutants, which we do not.
Therefore, although the studies herein do not preclude the
possibility of changes in GTPgS binding in the absence of a
change in GDP release, further studies will be required to
assess the likelihood of this potential outcome.
Nonetheless, despite the variations between the affinity shift
data and the GDP/GTP exchange rates for the Gai1 mutants,
the affinity shift activity appeared to show overall trends in the
same direction as the [35S]GTPgS binding data. We, therefore,
determined whether there was a correlation between affinity
shift activity and the initial rates of GDP/GTP exchange as
measured by [35S]GTPgS binding. Fig. 7 illustrates the correlative comparison between these two data sets. Correlation
analysis yielded a Pearson correlation coefficient of 0.80, indicating a significant correlation between the GDP/GTP exchange rate and the affinity shift activity.
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forms a hydrogen bond with both the side chain carboxyl
groups of Glu308 and with the g hydroxyl group of Thr321. In
contrast, Gat residue Lys300 forms a van der Waals interaction
with the d carbon on Leu304. Substitution of Gai1 residues
Gln304 and Glu308 with the corresponding amino acids from Gat
(Lys300 and Leu304) results in the loss of strong side chain
interactions (compare Gai and Gat contacts in Fig. 10B). This
suggests that these mutations might weaken the interaction of
the a4 helical domain with the b6 strand resulting in an a
subunit structure that is less responsive to 5-HT1B receptormediated conformational change.
DISCUSSION

FIG. 7. Correlation between GDP/GTP exchange and affinity
shift activity. The data plotted represent the means of each data set as
reported in Table I. Filled circle represents the Gai1 control value; open
circle represents Chi22; open squares represent Chi22 mutants; filled
squares represent Gai1 mutants. Chi24 is represented by 3, and Chi25
is represented by an asterisk. The Pearson correlation coefficient was
0.80, representing a significant correlation between both data sets.

Computer Simulation of Double Point Mutations Reveal Potential for Direct Interaction of Gln304 and Glu308 with the
5-HT1B Receptor—Whereas the present study demonstrates
the critical role of two specific amino acids within the a4 helical
domain of Gai1, this mutagenesis approach could not assess
whether the 5-HT1B receptor directly interacts with Gln304 and
Glu308 or whether these residues have an indirect effect on
receptor coupling as a result of structural changes that occur
secondary to amino acid substitution. As shown in Fig. 8, both
of these residues are potentially available for direct interaction
with the 5-HT1B receptor. In fact, the residues might represent
one contact point within a receptor-binding surface which also
includes the carboxyl-terminal a-helix of Gai1 and perhaps the
b6 strand (Fig. 8). To determine whether the Q304K-E308L
mutation could alter the surface electrostatic potential of Gai1,
we utilized the GRASP program (developed by A. Nicholls and
B. Honig, Columbia University) to compare the mutant a subunit (Gai1-Q304K-E308L) to native Gai1. The net molecular
charge of Gai1 is 23, whereas the net charge of the mutant is
21. As shown in Fig. 9A, Gai1 residues Gln304, Glu308, and
Thr321 produce a pocket of negative charge at the surface. The
Q304K-E308L mutation of Gai1 changes the surface potential
near these residues to a net positive charge. In addition, the
surfaces immediately surrounding these residues are now more
neutral than in native Gai1. The marked change in the surface
potential as a result of these mutations may alter the strength
of receptor contact with the a subunit.
Alternatively, rather than affecting direct contact sites with
the receptor, the amino acid substitutions within Gai1 may
have resulted in secondary structural changes in neighboring
domains. The a4 –b6 loop region of Gai1 and the b6 strand are
possible candidate domains for secondary disruptions consequent to amino acid mutation. The three-dimensional crystal
structures of both Gt and Gai1 show that the conformations of
the a4 helix and a4 –b6 loop are almost identical between these
subunits (Fig. 10A). Therefore, as the amino acid substitutions
that were generated in the present study were substitutions of
Gat residues for Gai1 residues, it is unlikely that these substitutions would have a marked effect on the secondary structure
in this domain. This contention is supported by the fact that all
mutant Ga subunits examined in the current study remain
capable of full activation by light-activated rhodopsin (data not
shown). However, as illustrated in Fig. 10B, Gln304 of Gai1

By using Gai/Gat chimeras and site-directed mutagenesis,
the present study determined that two residues (Gln304 and
Glu308) within the a4 helical domain of Gai1 are required for
5-HT1B receptor coupling to Gai1. These results are consistent
with our previous work implicating the a4 helix and a4 —b6
loop region of Gai1 in 5-HT1B receptor coupling to inhibitory G
proteins. Taken together, these studies provide evidence for a
previously unappreciated role for the a4 helix of a subunits in
directing G protein-coupled receptor interactions.
Previously published work has shown that there are several
receptor-binding regions present in heterotrimeric G proteins.
The primary receptor recognition region is believed to be localized to the carboxyl-terminal domain of Ga subunits (13–18),
although at least three other regions in Ga are involved in
receptor interaction: the amino-terminal domain (18, 20, 41);
the a2 helix and a2-b4 loop regions (16, 19); and the a4 helix
and a4-b6 loop domain (1, 16, 42). In addition, segments of the
b and g subunits may contribute to the receptor interacting
surface of heterotrimers (20 –25). Whether individual G protein-coupled receptors interact simultaneously with several regions on heterotrimers and/or whether the profile of physical
contacts for a particular receptor may direct more subtle features of specificity such as the efficiency of receptor coupling
remains to be determined.
Other studies implicating the a4 helix and/or a4 –b6 loop
regions of Ga in receptor interactions include studies from
alanine scanning mutagenesis on Gat (16), patterns of evolutionary conservation (43), and tryptic digestion of Gat bound to
rhodopsin (42). Interestingly, the recently resolved crystal
structure of Gas by Sunahara et al. (44) indicates that although
the overall structures of Gas and Gai are quite similar, the a4
helix and a4-b6 loop region varies between these subunits both
in the length of the helical domain and the positioning of this
region within the molecule itself (44). Thus the sequence divergence and structural differences between these Ga’s is consistent with an important role in specific receptor recognition.
According to the crystal structure of Gai (30), in three-dimensional space Gln304 and Glu308 are situated on the same molecular surface as the carboxyl-terminal tail of the Ga subunit
which has been well established as a receptor-binding site (Fig.
8). The a4 helix is connected to the carboxyl-terminal domain
via the a4-b6 loop, followed by the b6 strand and the b6 –a5
loop which contains a conserved guanine nucleotide binding
motif TCAT (Fig. 10A). Several biochemical studies have reported that mutations within this TCAT motif dramatically
decrease the affinity of the a subunit for GDP (16, 45, 46).
Therefore, one could hypothesize that the 5-HT1B receptor interaction with both the a4 helical domain and the carboxylterminal region might trigger changes in the b6 –a5 loop. Upon
agonist activation of the receptor, both domains may translate
a conformational change to the TCAT motif resulting in a
lowered affinity of GDP for the nucleotide binding pocket. Key
mutations within either one of these domains (i.e. the a4 helix
or carboxyl terminus) may alter the transmission of the recep-
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FIG. 8. Space filling model of the
GTP bound form of Gai1 highlighting
both known and hypothetical receptor contact sites on the Ga subunit.
Residues within the a4 helical domain
(purple), which were determined to be
critical for 5-HT1B receptor coupling
(Gln304 and Glu308), are colored orange to
illustrate that these residues are surfaceexposed and could potentially directly interact with the 5-HT1B receptor. A hypothetical receptor-binding site may also
include portions of the b6 strand (green)
as well as the a5 helical-carboxyl-terminal domain (fuchsia). The guanine nucleotide (orange) is shown buried within the
core of the a subunit. The model was generated using INSIGHT II (Biosym Technologies, San Diego, CA) with the crystal
structure coordinates from (30).

FIG. 9. Solvent-accessible surface of
a subunits colored according to the
electrostatic potential. The solvent-accessible surface of GTPgS-bound Gai1 (30)
and GDP-bound Chi6 (51) are shown in A
and C, respectively. Using INSIGHT II
(version 2.3.0 Viewer Module), computersimulated models of the crystal structures
of Gai1-Q304K-E308L and Chi6-K300QL304E were generated. The solvent-accessible surfaces of these mutants were
then calculated using the GRASP program (developed by A. Nicholls and B.
Honig, Columbia University). These models simulate the impact of the double mutation on the surface electrostatic potential of the a subunit. The electrostatic
potential is contoured in the range from
210kBT (red) to 110 kBT (blue) where kB
is Boltzmann’s constant and T is the absolute temperature (K). Amino acids are
labeled based on their relative sequence
positions (30, 31, 51, 52). C, carboxyl
terminus.

tor-induced conformational signal to the TCAT domain and
result in an inability to release GDP upon agonist binding.
Consistent with this idea, it has been suggested that the
agonist-activated receptor interacts with the GDP-bound form
of the heterotrimeric G protein, and the release of GDP from
the Ga subunit is the rate-limiting step in G protein activation
(47– 49). This guanine nucleotide free form of the G protein
exists in a highly stable complex with the agonist-bound receptor in the absence of guanine nucleotides in the medium (50).
Therefore, mutations of Gai that generate defects in agonistactivated receptor-catalyzed GDP release from the Ga subunit
should also result in a failure to establish the high affinity
ternary complex of agonist, receptor, and G protein. In fact, as
shown in Fig. 7, a good overall correlation does exist between

the two measurements of GTPgS binding and affinity shift
activity.
Sequence alignment and comparison of the primary structure between Gai/o family members reveals that a4 helical
residues Gln304 and Glu308 are absolutely conserved among the
members of the Gi/o family of a subunits shown in Fig. 11. In
contrast, residues in the homologous position on Gat are different. The conservation of these critical residues across Gai1,
Gai2, Gai3, and Gao members of the Gi/o family is consistent
with the ability of the 5-HT1B receptor to couple selectively to
heterotrimers containing any one of these members within this
family of a subunits (12). These data are also consistent with
published studies indicating that the 5-HT1B receptor is incapable of coupling to heterotrimers containing Gat (1, 12).
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FIG. 11. Primary sequence alignment of a4 helical region of Ga
subunits. Numbers above the sequences refer to amino acid positions
in the context of Gai1. Boldface letters represent identical amino acid
residues among Gai/o subunits. The circled amino acid residues in Gai1
are those that were determined to be critical for 5-HT1B receptor coupling. Notice that these amino acids are conserved among several members of the Gai/o family of a subunits but diverge from the corresponding
residues in Gat. bov., bovine; hum., human; cavpo., guinea pig.

same subfamily.
In summary, 2 amino acids within the a4 helix of the Ga
subunit play a key role in directing the specificity of 5-HT1B
receptor coupling. These residues are essential for ensuring
both the formation of the high affinity state of the receptor in
the presence of agonist and receptor-catalyzed GDP/GTP exchange. Conservation of these residues across several members
of the Gi/o family of a subunits strengthens the importance of
these residues in agonist G protein activation and suggests
that other receptors that distinguish between Gai and Gat may
utilize these residues as well. It remains to be determined
whether these residues interact directly with the receptor or
act indirectly by affecting the secondary structure of Ga or the
transmission of conformational changes to the GDP-binding
pocket. Future work on the generalizability of these results to
other Gi-coupled receptors will contribute to the understanding
of the mechanism of receptor-catalyzed G protein activation
and the nature of selectivity governing various cellular responses elicited by different biological stimuli.
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